Morishita Jintan Co., Ltd. (4524.T)

JPY 2097.0

(0.58%)

Net Income Summary of Morishita Jintan Co., Ltd.

  • Morishita Jintan Co., Ltd.'s latest annual net income in 2023 was 697 Million JPY , up 41.96% from previous year.
  • Morishita Jintan Co., Ltd.'s latest quarterly net income in 2024 Q1 was 245 Million JPY , up 744.74% from previous quarter.
  • Morishita Jintan Co., Ltd. reported an annual net income of 491 Million JPY in 2022, up 73.5% from previous year.
  • Morishita Jintan Co., Ltd. reported an annual net income of 283 Million JPY in 2021, up 37.38% from previous year.
  • Morishita Jintan Co., Ltd. reported a quarterly net income of 262 Million JPY for 2023 Q3, up 35.05% from previous quarter.
  • Morishita Jintan Co., Ltd. reported a quarterly net income of 194 Million JPY for 2023 Q2, down -30.47% from previous quarter.

Annual Net Income Chart of Morishita Jintan Co., Ltd. (2023 - 2019)

Historical Annual Net Income of Morishita Jintan Co., Ltd. (2023 - 2019)

Year Net Income Net Income Growth
2023 697 Million JPY 41.96%
2022 491 Million JPY 73.5%
2021 283 Million JPY 37.38%
2020 206 Million JPY -36.02%
2019 322 Million JPY 0.0%

Peer Net Income Comparison of Morishita Jintan Co., Ltd.

Name Net Income Net Income Difference
Pharma Foods International Co., Ltd. 3.2 Billion JPY 78.253%
Takeda Pharmaceutical Company Limited 144.06 Billion JPY 99.516%
Sumitomo Pharma Co., Ltd. -314.96 Billion JPY 100.221%
Shionogi & Co., Ltd. 162.03 Billion JPY 99.57%
Wakamoto Pharmaceutical Co.,Ltd. 108.95 Million JPY -539.69%
Nippon Shinyaku Co., Ltd. 25.85 Billion JPY 97.304%
Kaken Pharmaceutical Co., Ltd. 8.02 Billion JPY 91.315%
Eisai Co., Ltd. 42.4 Billion JPY 98.356%
Hisamitsu Pharmaceutical Co., Inc. 13.96 Billion JPY 95.01%
Mochida Pharmaceutical Co., Ltd. 4.54 Billion JPY 84.671%
Fuso Pharmaceutical Industries,Ltd. 1.37 Billion JPY 49.383%
Nippon Chemiphar Co., Ltd. -180 Million JPY 487.222%
Tsumura & Co. 16.7 Billion JPY 95.828%
Kissei Pharmaceutical Co., Ltd. 11.16 Billion JPY 93.754%
Torii Pharmaceutical Co., Ltd. 4.11 Billion JPY 83.078%
Towa Pharmaceutical Co., Ltd. 16.17 Billion JPY 95.69%
Fuji Pharma Co., Ltd. 3.43 Billion JPY 79.709%
Zeria Pharmaceutical Co., Ltd. 7.73 Billion JPY 90.985%
KYORIN Holdings, Inc. 5.32 Billion JPY 86.903%
Taiko Pharmaceutical Co.,Ltd. -4.89 Billion JPY 114.242%
Daito Pharmaceutical Co.,Ltd. 3.29 Billion JPY 78.847%
SymBio Pharmaceuticals Limited -1.96 Billion JPY 135.51%
MedRx Co., Ltd -932 Million JPY 174.785%
Mizuho Medy Co.,Ltd. 3.77 Billion JPY 81.533%
Solasia Pharma K.K. -1.11 Billion JPY 162.68%
Modalis Therapeutics Corporation -2.39 Billion JPY 129.141%
ASKA Pharmaceutical Holdings Co.,Ltd. 7.54 Billion JPY 90.762%
Sawai Group Holdings Co., Ltd. 13.69 Billion JPY 94.911%
Cyfuse Biomedical K.K. -589.21 Million JPY 218.294%
Toho Holdings Co., Ltd. 20.65 Billion JPY 96.626%
Koa Shoji Holdings Co.,Ltd. 2.94 Billion JPY 76.344%